Dr. Martin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1514 Cumberland Rd
Chapel Hill, NC 27514Phone+1 919-880-7590Fax+1 919-668-1180
Summary
- Dr. Paul Martin is a pediatric hematologist/oncologist in Durham, NC and is affiliated with Duke University Hospital. He received his medical degree from Washington University in St. Louis School of Medicine and has been in practice 30 years. He is experienced in bone marrow failure syndromes, hematopoietic stem cell transplantation, bone marrow transplantation, stem cell transplantation, and leukemia.
Education & Training
- Yale-New Haven Medical CenterFellowship, Pediatric Hematology/Oncology, 1989 - 1992
- Yale-New Haven Medical CenterResidency, Pediatrics, 1987 - 1989
- Washington University in St. Louis School of MedicineClass of 1987
- Washington University, School of MedicinePh.D., Molecular Biology and Biochemistry, 1987
- Harvard UniversityAB, Biochemistry, 1979
Certifications & Licensure
- FL State Medical License 2024 - 2027
- NC State Medical License 1992 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
- A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) Start of enrollment: 2023 Jan 25
Roles: Contact
Publications & Presentations
PubMed
- 88 citationsThree-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.Theodore W Laetsch, Shannon L Maude, Susana Rives, Hidefumi Hiramatsu, Henrique Bittencourt
Journal of Clinical Oncology. 2023-03-20 - 7 citationsPediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.Matthew Barth, Ana C Xavier, Saro Armenian, Anthony N Audino, Lindsay Blazin
Journal of the National Comprehensive Cancer Network. 2022-11-01 - 5 citationsOutcomes of pediatric patients with therapy-related myeloid neoplasms.Akshay Sharma, Sujuan Huang, Ying Li, Russell J. Brooke, Ibrahim Ahmed
Bone Marrow Transplantation. 2021-09-03
Journal Articles
- Management Guidelines for Paediatric Patients Receiving Chimeric Antigen Receptor T Cell TherapyKris M Mahadeo, Julie C Fitzgerald, Marie E Steiner, Partow Kebriaei, Katayoun Rezvani, Ira M Cheifetz, John M Slopis, Paul L Martin, Sattva S Neelapu, Agne Tarasevici..., Nature
- Therapeutic Monitoring of Voriconazole in Children Less Than 3 Years of Age: A Case Report and Summary of Voriconazole Concentrations for 10 ChildrenDoby EH, Benjamin DK Jr, Blaschke AJ, Ward RM, Pavia AT, MARTIN PL, Driscoll TA, Cohen-Wolkowiez M, Moran C, Pediatr Infect Dis J, 6/1/2012
- ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemiaXu H, Cheng C, Devidas M, Pei D, Fan Y, Yang W, Neale G, Scheet P, Burchard EG, Torgerson DG, Eng C, Dean M, Antillon F, Winick NJ, MARTIN, PL, Willman CL, Camitta BM,..., J Clin Oncol, 3/1/2012
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: